Skip to content

ICL Group

US · ICL #1851 by market cap Listed 1970
4.08 -0.06 -1.45%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Company notice
    ICL Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
    SEC · 2026/11/11
  • Rating change
    KingMed Diagnostics (603882): The ICL industry is gradually stabilizing, and the company's profitability has improved significantly.
    Citic Securities · 2026/9/30
  • ICL Group Q3 2026 Earnings Conference Call Transcript
    CSOP · 2026/11/12
  • Rating change
    Barclays Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6
    Market Newswire · 2026/7/27
  • Rating change
    Morgan Stanley Initiates ICL Group(ICL.US) With Hold Rating, Announces Target Price $5.45
    Market Newswire · 2026/10/16
  • BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6
    Market Newswire · 2026/11/12
  • Rating change
    ICL Group Is Maintained at Equal-Weight by Barclays
    Dow Jones · 2026/5/18
  • Barclays Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6
    Market Newswire · 2026/11/11
  • Rating change
    Barclays Maintains Equal-Weight on ICL Group, Raises Price Target to $7
    Benzinga · 2026/5/18
  • Company notice
    ICL Group | 6-K: Report of foreign private issuer (related to financial reporting)
    SEC · 2026/11/11
  • Aier Eye Hospital (300015.SZ): In the third quarter of 2026, the proportion of advanced surgical procedures such as ICL V5, SMILE Pro, and Quan Guang Su continued to rise, driving a significant sequential increase in revenue.
    Gelonghui Finance · 2026/11/12
  • Company notice
    ICL Group | 6-K: Report of foreign private issuer (related to financial reporting)
    SEC · 2026/11/11
  • Rating change
    ICL Group Price Target Raised to $7.00/Share From $6.00 by Barclays
    Dow Jones · 2026/5/18
  • Company notice
    ICL Group | SCHEDULE 13G: Others
    SEC · 2026/11/3
  • ICL Group To Go Ex-Dividend On December 2nd, 2026 With 0.0488 USD Dividend Per Share
    Market Newswire · 2026/11/12
  • Company notice
    ICL Group | 6-K: Report of foreign private issuer (related to financial reporting)
    SEC · 2026/11/11
  • Rating change
    BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $6.5
    Market Newswire · 2026/5/20
  • Rating change
    Morgan Stanley Initiates ICL Group(ICL.US) With Hold Rating, Announces Target Price $5.75
    Market Newswire · 2026/8/10
  • Rating change
    BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6
    Market Newswire · 2026/8/6
  • Rating change
    Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $5.6
    Market Newswire · 2026/7/22
  • Barclays Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6
    Market Newswire · 2026/10/16
  • Company notice
    ICL Group | 4: Statement of changes in beneficial ownership of securities
    SEC · 2026/8/6
  • Company notice
    ICL Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
    SEC · 2026/9/18
  • Rating change
    Barclays Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $7
    Market Newswire · 2026/5/18
  • Company notice
    ICL Group | SD: Specialized disclosure report
    SEC · 2026/9/25

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

ICL Group discussion 0 comments

Add a comment